MDGL - MADRIGAL PHARMACEUTICALS, INC.


434.8
8.950   2.058%

Share volume: 265,096
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.72%

PREVIOUS CLOSE
CHG
CHG%

$425.85
8.95
0.02%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2024 06-30-2024 09-30-2024 12-31-2024 03-31-2025 06-30-2025 09-30-2025 12-31-2025
Fiscal Quarter Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Report Date 05-07-2024 08-07-2024 10-31-2024 02-26-2025 05-01-2025 08-05-2025 11-04-2025 02-19-2026
Total revenue 0.000 14.638 M 62.175 M 103.320 M 137.250 M 212.802 M 287.268 M 321.083 M
Cost of revenue 0.000 0.000 0.000 6.233 M 0.000 0.000 0.000 0.000
Gross profit 0.000 14.638 M 62.175 M 97.087 M 137.250 M 212.802 M 287.268 M 321.083 M
    inf% 324.75% 56.15% 41.37% 55.05% 34.99% 11.77%  
Operating expenses 152.037 M 177.175 M 178.479 M 164.084 M 216.561 M 260.004 M 401.243 M 380.692 M
Selling general and admin 80.800 M 106.084 M 109.737 M 138.436 M 172.389 M 205.923 M 227.239 M 264.424 M
Research and development 71.237 M 71.091 M 68.742 M 25.648 M 44.172 M 54.081 M 174.004 M 116.268 M
Total expenses 152.037 M 177.175 M 178.479 M 164.084 M 216.561 M 260.004 M 401.243 M 380.692 M
    16.53% 0.74% -8.07% 31.98% 20.06% 54.32% -5.12%  
Operating income -152.037 M -162.537 M -116.304 M -66.997 M -79.311 M -47.202 M -113.975 M -59.609 M
Ebit -152.037 M -162.537 M -116.304 M -66.997 M -79.311 M -47.244 M -114.268 M -59.609 M
Pretax income -147.541 M -151.971 M -106.964 M -59.416 M -73.238 M -42.281 M -114.190 M -58.575 M
    3.00% -29.62% -44.45% 23.26% -42.27% 170.07% -48.70%  
Income tax 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Net income basic 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
                   
Net income -147.541 M -151.971 M -106.964 M -59.416 M -73.238 M -42.281 M -114.190 M -58.575 M
    -3.00% 29.62% 44.45% -23.26% 42.27% -170.07% 48.70%